1. Home
  2. GH
  3. GH News

Latest Guardant Health Inc. (GH) News on August 24, 2025

The Top 5 Analyst Questions From Guardant Health’s Q1 Earnings Call
GH

StockStory

2 months ago

The Top 5 Analyst Questions From Guardant Health’s Q1 Earnings Call

TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?
GH

Zacks

2 months ago

TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?

Medical Services Name Flirts With A Buy Point
GH

Investor's Business Daily

2 months ago

Medical Services Name Flirts With A Buy Point

GH

MT Newswires

2 months ago

Guardant Health Insider Sold Shares Worth $322,819, According to a Recent SEC Filing

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?
GH

Zacks

2 months ago

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?

Dow Jones Futures Rise As Trump Buys Time For Iran; Tesla Robotaxi To Have Safety Monitor
GH

Investor's Business Daily

2 months ago

Dow Jones Futures Rise As Trump Buys Time For Iran; Tesla Robotaxi To Have Safety Monitor

3 of Wall Street’s Favorite Stocks Facing Headwinds
GH

StockStory

2 months ago

3 of Wall Street’s Favorite Stocks Facing Headwinds

2 Mooning Stocks Worth Your Attention and 1 to Be Wary Of
GH

StockStory

2 months ago

2 Mooning Stocks Worth Your Attention and 1 to Be Wary Of

Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening
GH

Business Wire

2 months ago

Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening

GH

MT Newswires

2 months ago

Guardant Health Insider Sold Shares Worth $5,974,364, According to a Recent SEC Filing

New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer
GH

Business Wire

2 months ago

New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer

Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?
GH

Zacks

3 months ago

Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?

Guardant Health’s MCD test earns FDA breakthrough designation
GH

Medical Device Network

3 months ago

Guardant Health’s MCD test earns FDA breakthrough designation

Why Guardant Health Stock Surged Nearly 9% Higher Today
GH

Motley Fool

3 months ago

Why Guardant Health Stock Surged Nearly 9% Higher Today

GH

MT Newswires

3 months ago

Guardant Health's Shield Multi-Cancer Test Receives FDA Breakthrough Device Designation

FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) Test
GH

Business Wire

3 months ago

FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) Test

National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening
GH

Business Wire

3 months ago

National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening

SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advanced Breast Cancer
GH

Business Wire

3 months ago

SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advanced Breast Cancer

Testing & Diagnostics Services Stocks Q1 Teardown: Quest (NYSE:DGX) Vs The Rest
GH

StockStory

3 months ago

Testing & Diagnostics Services Stocks Q1 Teardown: Quest (NYSE:DGX) Vs The Rest

In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment Decisions
GH

Business Wire

3 months ago

In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment Decisions

Guardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and Biomarkers
GH

Insider Monkey

3 months ago

Guardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and Biomarkers

Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way
GH

StockStory

3 months ago

Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way

Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test
GH

Business Wire

3 months ago

Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test

New Tests Promise to Reveal the Secrets in Your Blood
GH

The Wall Street Journal

3 months ago

New Tests Promise to Reveal the Secrets in Your Blood

Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting
GH

Business Wire

3 months ago

Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
GH

StockStory

3 months ago

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know

Guardant Health (GH) introduces IHC Solid Tumor Testing to its Portfolio
GH

Insider Monkey

3 months ago

Guardant Health (GH) introduces IHC Solid Tumor Testing to its Portfolio

GH

MT Newswires

3 months ago

Guardant Health Launches Immunohistochemistry Testing for Solid Tumors

Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors
GH

Business Wire

3 months ago

Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors

Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer
GH

Business Wire

3 months ago

Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer

GH Q1 Earnings Call: Guardant Health Lifts Full-Year Guidance Following Oncology and Screening Momentum
GH

StockStory

3 months ago

GH Q1 Earnings Call: Guardant Health Lifts Full-Year Guidance Following Oncology and Screening Momentum

Guardant Health to Participate in Upcoming Investor Conferences
GH

Business Wire

4 months ago

Guardant Health to Participate in Upcoming Investor Conferences

TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year
GH

Business Wire

4 months ago

TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GH

Business Wire

4 months ago

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GH

MT Newswires

4 months ago

Guardant Health Insider Sold Shares Worth $5,936,572, According to a Recent SEC Filing

Guardant Health, Inc. (NASDAQ:GH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$59.17
GH

Simply Wall St.

4 months ago

Guardant Health, Inc. (NASDAQ:GH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$59.17

GH

MT Newswires

4 months ago

Morgan Stanley Raises Price Target on Guardant Health to $60 From $52, Keeps Overweight Rating

Guardant Health First Quarter 2025 Earnings: Beats Expectations
GH

Simply Wall St.

4 months ago

Guardant Health First Quarter 2025 Earnings: Beats Expectations

GH

Morningstar Research

4 months ago

Analyst Report: Guardant Health, Inc.

GH

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Guardant Health Inc Earnings Call

GH

MT Newswires

4 months ago

UBS Adjusts Guardant Health Price Target to $70 From $65, Maintains Buy Rating

GH

MT Newswires

4 months ago

Guardant Health Q1 Adjusted Loss Widen, Revenue Rises; 2025 Revenue Guidance Raised

Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
GH

GuruFocus.com

4 months ago

Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates
GH

Zacks

4 months ago

Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates

Guardant Health’s (NASDAQ:GH) Q1: Strong Sales, Stock Soars
GH

StockStory

4 months ago

Guardant Health’s (NASDAQ:GH) Q1: Strong Sales, Stock Soars

GH

Associated Press Finance

4 months ago

Guardant Health: Q1 Earnings Snapshot

Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
GH

Business Wire

4 months ago

Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
GH

Business Wire

4 months ago

Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types

Guardant Health (GH) Q1 Earnings Report Preview: What To Look For
GH

StockStory

4 months ago

Guardant Health (GH) Q1 Earnings Report Preview: What To Look For

GH

MT Newswires

4 months ago

Guardant Health Launches Molecular Profiling Cancer Test

CORRECTING and REPLACING Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer
GH

Business Wire

4 months ago

CORRECTING and REPLACING Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer

GH

MT Newswires

4 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform
GH

Benzinga

4 months ago

Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform

GH

MT Newswires

4 months ago

Guardant Health, Pfizer Begin Partnership to Test Prospective Cancer Therapies in China

Amgen (AMGN) Earnings Expected to Grow: Should You Buy?
GH

Zacks

4 months ago

Amgen (AMGN) Earnings Expected to Grow: Should You Buy?

Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform
GH

Business Wire

4 months ago

Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform

Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline
GH

Zacks

4 months ago

Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline

Guardant Health (GH) Rose Following Several Positive News Reports
GH

Insider Monkey

4 months ago

Guardant Health (GH) Rose Following Several Positive News Reports

Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR
GH

Business Wire

4 months ago

Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR

RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know
GH

StockStory

4 months ago

RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know

3 Reasons to Sell GH and 1 Stock to Buy Instead
GH

StockStory

4 months ago

3 Reasons to Sell GH and 1 Stock to Buy Instead

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
GH

Investor's Business Daily

4 months ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Guardant Health price target raised to $60 from $56 at BofA
GH

TipRanks

4 months ago

Guardant Health price target raised to $60 from $56 at BofA

GH

MT Newswires

4 months ago

BofA Securities Raises Price Target on Guardant Health to $60 From $56, Keeps Buy Rating

Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025
GH

Business Wire

4 months ago

Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025

GH

MT Newswires

4 months ago

Mizuho Initiates Guardant Health at Outperform

Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)
GH

StockStory

5 months ago

Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
GH

Business Wire

5 months ago

Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada

3 Small-Cap Stocks in the Doghouse
GH

StockStory

5 months ago

3 Small-Cap Stocks in the Doghouse

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
GH

Zacks

5 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries
GH

Business Wire

5 months ago

Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries

These Seven Risky Bets Take The Shine Off Gold; One Looks To Extend 46% Gain
GH

Investor's Business Daily

5 months ago

These Seven Risky Bets Take The Shine Off Gold; One Looks To Extend 46% Gain

1 Healthcare Stock on Our Watchlist and 2 to Turn Down
GH

StockStory

5 months ago

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

GH

Morningstar Research

5 months ago

Analyst Report: Guardant Health, Inc.

GH

MT Newswires

5 months ago

Update: Guardant Health Shares Soar After Colorectal Cancer Test Granted ADLT Status

GH

MT Newswires

5 months ago

Guardant Health Says Colorectal Cancer Test Granted ADLT Status

Guardant Health Receives ADLT Status From CMS for Shield Blood Test
GH

Business Wire

5 months ago

Guardant Health Receives ADLT Status From CMS for Shield Blood Test

GH

Morningstar Research

5 months ago

Analyst Report: Guardant Health, Inc.

GH

MT Newswires

6 months ago

Guardant Health Base Business in 'Fundamentally Good Shape,' Morgan Stanley Says

GH

MT Newswires

6 months ago

Morgan Stanley Adjusts Price Target on Guardant Health to $52 From $42, Keeps Overweight Rating

Guardant Health Joins Forces With Dak Prescott’s Faith Fight Finish Foundation and Feist-Weiller Cancer Center’s Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities
GH

Business Wire

6 months ago

Guardant Health Joins Forces With Dak Prescott’s Faith Fight Finish Foundation and Feist-Weiller Cancer Center’s Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities

Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue
GH

StockStory

6 months ago

Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GH

Business Wire

6 months ago

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change
GH

Business Wire

6 months ago

New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change

Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts
GH

Insider Monkey

6 months ago

Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts

Is Guardant Health (GH) Outperforming Other Medical Stocks This Year?
GH

Zacks

6 months ago

Is Guardant Health (GH) Outperforming Other Medical Stocks This Year?

Guardant accuses Natera of poaching employees, stealing trade secrets
GH

MedTech Dive

6 months ago

Guardant accuses Natera of poaching employees, stealing trade secrets

Guardant Health price target raised to $56 from $42 at TD Cowen
GH

TipRanks

6 months ago

Guardant Health price target raised to $56 from $42 at TD Cowen

Guardant Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
GH

Simply Wall St.

6 months ago

Guardant Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
GH

Investor's Business Daily

6 months ago

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
GH

Benzinga

6 months ago

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?

GH

MT Newswires

6 months ago

UBS Adjusts Guardant Health Price Target to $65 From $40, Maintains Buy Rating

GH

Morningstar Research

6 months ago

Analyst Report: Guardant Health, Inc.

Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
GH

GuruFocus.com

6 months ago

Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say
GH

Zacks

6 months ago

Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say

Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates
GH

Zacks

6 months ago

Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates

GH

Associated Press Finance

6 months ago

Guardant Health: Q4 Earnings Snapshot

GH

MT Newswires

6 months ago

Guardant Health Q4 Adjusted Loss Narrows, Revenue Rises; 2025 Sales Guidance Set

Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
GH

Business Wire

6 months ago

Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Why Guardant Health, Inc. (GH) is the Best Performing Healthcare Stock So Far in 2025
GH

Insider Monkey

6 months ago

Why Guardant Health, Inc. (GH) is the Best Performing Healthcare Stock So Far in 2025

Share on Social Networks: